Abstract
Eighteen elderly patients aged 76 years or older with small cell lung cancer were treated with carboplatin (AUC = 4 mg/ml.min, i.v. day 1) and etoposide (70 mg/m2 i.v. day 1-3) and 17 patients were evaluable. The median age of the study population was 77 years (range: 76-81). Eight patients had limited disease (LD) and nine did extensive disease (ED). The overall response rate was 88% for LD patients and 67% for ED patients. Median survival time was 219 days for LD patients and 158 days for ED patients. Grade 3 and 4 leukopenia, neutropenia, thrombocytopenia and anemia occurred in 41%, 76%, 24% and 6% of patients, respectively. There was one treatment-related death due to pneumonitis.
Original language | English |
---|---|
Pages (from-to) | 751-756 |
Number of pages | 6 |
Journal | Gan to kagaku ryoho. Cancer & chemotherapy |
Volume | 29 |
Issue number | 5 |
Publication status | Published - May 2002 |
ASJC Scopus subject areas
- Medicine(all)